Brief: Qualigen Therapeutics Says Co Granted Until Oct 31, 2024 To Regain Compliance With Nasdaq Rules
Aug 5 (Reuters) - Qualigen Therapeutics Inc QLGN.O :
* QUALIGEN THERAPEUTICS : GRANTED UNTIL OCT 31, 2024 TO
REGAIN
COMPLIANCE WITH NASDAQ RULES
Source text for Eikon: ID:n0001493152-24-030244
Further company coverage: QLGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on FF EAI Robotics Ecosystem
See all newsBrief: Faraday Future Intelligent Electric Says FFR To Operate Robotics Business
Brief: Faraday Future Signs Deal to Transfer Robotics Business to FFR at $200 Mln Valuation
Faraday Future climbs after robotics unit deal, strategic upgrade into robotaxi operator
Brief: Aixcrypto Provides Context On Schedule 14C Filing
NASDAQ RESUMED AT 12:42 PM